Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-23ARWR144James Hamilton plan to sell securities of Arrowhead Pharmaceuticals Inc. under Form 144MEDIUM
James Hamilton filed Form 144 to notify SEC of plan to sell 10000 units of Arrowhead Pharmaceuticals Inc. securities around 2026-04-23, with aggregate market value of $749,997.60. The total outstanding units is 140032190.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions i...
Large CapBiotechnology
2026-04-23RCUS144JENNIFER JARRETT plan to sell securities of ARCUS BIOSCIENCES, INC. under Form 144MEDIUM
JENNIFER JARRETT filed Form 144 to notify SEC of plan to sell 53826 units of ARCUS BIOSCIENCES, INC. securities around 2026-04-23, with aggregate market value of $1,356,562.11. The total outstanding units is 125349476.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in p...
Mid CapBiotechnology
2026-04-23IRD144YERXA BENJAMIN R plan to sell securities of Opus Genetics, Inc. under Form 144MEDIUM
YERXA BENJAMIN R filed Form 144 to notify SEC of plan to sell 7470 units of Opus Genetics, Inc. securities around 2026-04-23, with aggregate market value of $39,121.14. The total outstanding units is 71150000.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-04-23IRD144SCHACHLE JOSEPH K plan to sell securities of Opus Genetics, Inc. under Form 144MEDIUM
SCHACHLE JOSEPH K filed Form 144 to notify SEC of plan to sell 4697 units of Opus Genetics, Inc. securities around 2026-04-23, with aggregate market value of $24,519.28. The total outstanding units is 71150000.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 mo...
Small CapBiotechnology
2026-04-23Opus Genetics, Inc.144SCHACHLE JOSEPH K plan to sell securities of Opus Genetics, Inc. under Form 144DuplicateMEDIUM
SCHACHLE JOSEPH K filed Form 144 to notify SEC of plan to sell 4697 units of Opus Genetics, Inc. securities around 2026-04-23, with aggregate market value of $24,519.28. The total outstanding units is 71150000.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 mo...
Small CapBiotechnology
2026-04-23Opus Genetics, Inc.144YERXA BENJAMIN R plan to sell securities of Opus Genetics, Inc. under Form 144DuplicateMEDIUM
YERXA BENJAMIN R filed Form 144 to notify SEC of plan to sell 7470 units of Opus Genetics, Inc. securities around 2026-04-23, with aggregate market value of $39,121.14. The total outstanding units is 71150000.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology